"It is intended that the data from the ongoing BNC210 trial in...

  1. 1,415 Posts.
    lightbulb Created with Sketch. 286
    "It is intended that the data from the ongoing BNC210 trial in Agitation will be
    analysed by dose and by measures of exposure given the PTSD trial learnings.
    Consequently, this trial is anticipated to read out in Q2, 2019."
    "Greenhill & Co was appointed to conduct a thorough and independent
    review of the strategic options with an update expected to be announced in Q2CY2019 together with
    the results of the BNC210 Phase 2 clinical trial for the treatment of Agitation in the Elderly."
    https://hotcopper.com.au/documentembed?id=uOMxKKzFkiWRTLKhOROKAxjvSDYL4g2+zxb+v/V38LFiGug=

    So first top line results of the Agitation trial due by 30th June. Is to be reported at the same time as the Independent strategic review results by Greenhill & Co.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.